• Claim your 0.75h CE/CME Credit Here

  • What best describes your title?*
  • If MD/DO
  • If RN/NP
  • If PharmD
  • Where are you based?
  • How did you FIRST hear about our tweetorials?
  • 1. Of the following risk factors, which is most significant for NTM-PD?*
  • 2. Your patient: A 68-year-old woman with extensive fibrocavitary MAC NTM-PD, initially AFB 3+, macrolide susceptible, treated for 6 months with initial IV amikacin and a standard triple oral regimen.  Sputum continues to grow MAC.  What should you do next?*
  • 3. Did you follow the entire tweetorial?*
  • 4. Did you find this to be an effective learning tool?*
  • 6. How will the program change your practice?*
  • 7. Will you recommend @pulmmed_ce and/or this website to your colleagues?*
  •  - -
    2 digit month, 2 digit day, 4 digit year
  • Should be Empty: